The 39-patient Study Found That Those Taking 5-7mg Of Cbd/kg Experienced An 84% Reduction In Motor Seizures With Seven Reporting Complete Elimination Of Any Seizures Over A Four Month Period Without Any Adverse Side-effects.

Saul Garza Morales, which evaluated the effects of RSHO-X on treating children with severe epilepsy. The 39-patient study found that those taking 5-7mg of CBD/kg experienced an 84% reduction in motor seizures with seven reporting complete elimination of any seizures over a four month period without any adverse side-effects. Epilepsy is a common and chronic neurological disorder that affects over 50 million people worldwide. In Mexico, 1.5 million patients have epilepsy with 80% of patients receiving inadequate treatment and 30% having refractory epilepsy, which fails to respond to common anti-epileptic drugs. Medical Marijuana’s RSHO-X is designed to address these patient populations with an effective and affordable alternative. Medical Marijuana Inc. has built a grassroots brand for its RSHO-X and related products Medical marijuana across Mexico, Brazil, Paraguay, Argentina, and other countries/territories. The company begins by securing importation rights into these countries, which helps set its brands apart from unlicensed competitors. Then, the company validates its products by working with physicians and researchers to demonstrate the effectiveness of CBD oils in treating a variety of different conditions.

To read more visit http://www.marketwatch.com/story/new-studies-continue-to-validate-medical-marijuana-incs-otc-mjna-rsho-x-nutraceutical-brand-in-mexico—-cfn-media-2017-04-06